SK Biotech & SK Life Science Overview
- Founded
-
1993
- Status
-
Private
- Employees
-
360
- Latest Deal Type
-
Merger of Eq.
- Financing Rounds
-
1
- Investments
-
1
SK Biotech & SK Life Science General Information
Description
Producer of raw materials for medicines. The company produces and distributes chemicals needed in medicine preparation. It specializes in conventional synthetic chemistry and continuous flow chemistry.
Contact Information
Website
www.skbiotek.com
Formerly Known As
SK Biotek Company, SK Life Science
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Commodity Chemicals
Primary Office
- 22-10 Route 208 South
- Fair Lawn, NJ 07410
- United States
+1 (201) 000-0000
SK Biotech & SK Life Science Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SK Biotech & SK Life Science Patents
SK Biotech & SK Life Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2006508152-A | Process for producing 10h-dibenzo [b, f] [1,4] thiazepin-11-one | Pending | 28-Nov-2002 | 0000000000 | 0 |
| US-20070066589-A1 | Reacting dithiodisalicylic acid with 1-chloro-2-nitrobenzene in a basic aqueous solution; reducing the nitro group of the 2-(2-nitrophenylthio)benzoic acid formed with hydrogen gas, a solvent and a heterogeneous metal catalyst; and cyclizing the product in an organic solvent | Granted | 28-Nov-2002 | 0000000000 | |
| US-7214793-B2 | Reacting dithiodisalicylic acid with 1-chloro-2-nitrobenzene in a basic aqueous solution; reducing the nitro group of the 2-(2-nitrophenylthio)benzoic acid formed with hydrogen gas, a solvent and a heterogeneous metal catalyst; and cyclizing the product in an organic solvent | Expired - Fee Related | 28-Nov-2002 | 0000000000 | 0 |
| EP-1565448-A4 | Method of preparing 10h-dibenzo b,f 1,4 thiazepin-11-one | Withdrawn | 28-Nov-2002 | 0000000000 | 0 |
| EP-1565448-A2 | Method of preparing 10h-dibenzo b,f 1,4 thiazepin-11-one | Withdrawn | 28-Nov-2002 | C07D281/16 | 0 |
SK Biotech & SK Life Science Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Junku Park Ph.D | Chief Executive Officer | ||
| Jaeyon Yoon Ph.D | Vice President & Head of Global Marketing |
SK Biotech & SK Life Science Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SK Biotech & SK Life Science Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00 000000 000 | 31-Dec-2017 | 0000000000 | Pharmaceuticals | 00000 000 |
SK Biotech & SK Life Science Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00 000000 0000000 | Pharmaceuticals | Dublin, Ireland | 0000 |